GSK is recalling two specific batches of Ventolin (salbutamol) 200mcg Accuhaler devices from patients and one specific batch of Seretide (salmeterol xinafoate, fluticasone propionate) 50/250mcg Accuhaler devices from hospitals, pharmacies, dispensing practices, retailers and wholesalers.
The action follows a manufacturing issue that the pharma giant says may result in a small number of Accuhaler devices not delivering the full number of doses in the device.
No other GSK inhalers are affected by this issue, the company maintains, and says it is important to note, the more commonly used ‘boot’-shaped Ventolin Evohaler ‘rescue’ inhaler is not affected by the recall.
The two Lots of Ventolin Accuhaler being recalled are: 786G and 754P. The one Lot of Seretide Accuhaler devices from hospitals, pharmacies, dispensing practices, retailers and wholesalers being recalled is 5K8W.
GSK's full statement is available here.